Local Drug Delivery Strategies for Glioblastoma Treatment

Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various dru...

Full description

Saved in:
Bibliographic Details
Published inBrain tumor research and treatment Vol. 10; no. 3; pp. 151 - 157
Main Authors Cha, Gi Doo, Jung, Sonwoo, Choi, Seung Hong, Kim, Dae-Hyeong
Format Journal Article
LanguageEnglish
Published The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology 01.07.2022
대한뇌종양학회
Subjects
Online AccessGet full text
ISSN2288-2405
2288-2413
2288-2413
DOI10.14791/btrt.2022.0017

Cover

Abstract Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM.Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM.
AbstractList Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM.Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM.
Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM.
Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the lim- ited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/ or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. There- fore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of che- motherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM. KCI Citation Count: 0
Author Choi, Seung Hong
Kim, Dae-Hyeong
Jung, Sonwoo
Cha, Gi Doo
AuthorAffiliation 1 Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea
4 Department of Materials Science and Engineering, College of Engineering, Seoul National University, Seoul, Korea
2 School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul, Korea
3 Department of Radiology, Seoul National University College of Medicine, Seoul, Korea
AuthorAffiliation_xml – name: 2 School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul, Korea
– name: 3 Department of Radiology, Seoul National University College of Medicine, Seoul, Korea
– name: 1 Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea
– name: 4 Department of Materials Science and Engineering, College of Engineering, Seoul National University, Seoul, Korea
Author_xml – sequence: 1
  givenname: Gi Doo
  orcidid: 0000-0002-4771-3396
  surname: Cha
  fullname: Cha, Gi Doo
  organization: Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea., School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul, Korea., Department of Radiology, Seoul National University College of Medicine, Seoul, Korea
– sequence: 2
  givenname: Sonwoo
  orcidid: 0000-0002-3797-8024
  surname: Jung
  fullname: Jung, Sonwoo
  organization: Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea., School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul, Korea
– sequence: 3
  givenname: Seung Hong
  orcidid: 0000-0002-0412-2270
  surname: Choi
  fullname: Choi, Seung Hong
  organization: Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea., Department of Radiology, Seoul National University College of Medicine, Seoul, Korea
– sequence: 4
  givenname: Dae-Hyeong
  orcidid: 0000-0002-4722-1893
  surname: Kim
  fullname: Kim, Dae-Hyeong
  organization: Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea., School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul, Korea., Department of Materials Science and Engineering, College of Engineering, Seoul National University, Seoul, Korea
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002863747$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqFkM1r3DAQxUVJaT7PvfoYCrsZSbZlXQIhaZPAQqHZu5Dl0VaNbG0lOWX_-9rZ0NIc0tMMzO-9mXnH5GAIAxLykcKSlkLSizbHvGTA2BKAinfkiLGmWbCS8oM_PVSH5CylHzAhrKqEEB_IIa8kk5SyIyJXwWhf3MRxU9ygd08Yd8VDjjrjxmEqbIjFrXeh9Trl0OtiHVHnHod8St5b7ROevdQTsv7yeX19t1h9vb2_vlotDGdMLCxYJmpNO9oghwoBOg3MSM6NsbqUJa8FUixFyym2jNZN17XcUtHW1laWn5BPe9shWvVonAraPddNUI9RXX1b3ysKwGTTiAmGPTwOW737pb1X2-h6HXcTo55DU3Noag5NzaFNksu9ZDu2PXZm-izqv7J527-TwX2fdj8pyStOa5gMzl8MYvg5Ysqqd8mg93rAMCbFaikFNCXwCa32qIkhpYhWGZd1dmF2dv6NGy9e6f731W_KMqVc
CitedBy_id crossref_primary_10_3390_ph17030300
crossref_primary_10_3390_cells13040363
crossref_primary_10_1002_smll_202303073
crossref_primary_10_3390_gels10100640
crossref_primary_10_1002_anbr_202400126
crossref_primary_10_1186_s12916_024_03775_4
crossref_primary_10_25259_SNI_588_2024
crossref_primary_10_3390_futurepharmacol5010007
crossref_primary_10_2147_IJN_S450853
crossref_primary_10_1021_acs_chemrev_3c00548
crossref_primary_10_1021_acsnano_3c03409
crossref_primary_10_1007_s12033_024_01287_3
crossref_primary_10_1016_j_addr_2023_114853
crossref_primary_10_1002_adhm_202303563
crossref_primary_10_15283_ijsc23062
crossref_primary_10_1016_j_ijbiomac_2025_140025
crossref_primary_10_1021_acs_biomac_3c00846
crossref_primary_10_1007_s11060_024_04763_7
Cites_doi 10.1002/adhm.201801660
10.1021/acsnano.6b05070
10.1016/j.biomaterials.2009.01.003
10.1021/acs.chemrev.1c00531
10.3390/pharmaceutics14020254
10.3390/ijms222313160
10.1038/srep43271
10.1016/j.jconrel.2017.08.019
10.2147/PPA.S93020
10.1038/s41467-019-13198-y
10.1016/j.jocn.2009.09.004
10.1038/nnano.2017.54
10.1016/j.jconrel.2018.05.008
10.18632/oncotarget.8837
10.1038/s41582-022-00621-0
10.1146/annurev-chembioeng-101420-024336
10.1038/nmat3878
10.1016/j.jconrel.2017.03.007
10.1016/j.jconrel.2020.09.002
10.1126/scitranslmed.aag2942
10.1073/pnas.97.12.6242
10.1021/nn503735w
10.4329/wjr.v3.i11.266
10.1039/D0NR01456G
10.1038/s41467-019-09853-z
10.1016/j.jinf.2013.12.002
10.1038/natrevmats.2016.14
10.1002/adma.202100425
10.1038/s41467-021-21117-3
10.1038/s41565-020-00843-7
10.1016/j.copbio.2021.07.027
10.1016/j.biomaterials.2020.119793
10.1016/S1470-2045(18)30665-X
10.1038/nrn1824
10.1038/s41467-019-14036-x
10.1021/acsnano.8b06201
10.1056/NEJMcibr1309402
10.1038/nrd1414
10.1002/adhm.202100614
10.1016/j.matt.2020.10.020
10.3390/ma11050779
10.3389/fonc.2018.00419
10.1038/s41565-021-00879-3
10.1016/j.ijpharm.2019.01.042
10.1093/neuonc/5.2.79
10.1016/j.jconrel.2018.05.005
10.1038/srep19077
10.1126/sciadv.abd4639
10.1038/s41551-021-00728-7
10.1021/acsmaterialslett.1c00438
10.1038/s41598-019-54283-y
10.1021/nn504210g
10.1021/acsnano.1c07649
10.1615/CritRevOncog.2014011455
ContentType Journal Article
Copyright Copyright © 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology.
Copyright © 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology
Copyright_xml – notice: Copyright © 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology.
– notice: Copyright © 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology
DBID AAYXX
CITATION
7X8
5PM
ADTOC
UNPAY
ACYCR
DOI 10.14791/btrt.2022.0017
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


Database_xml – sequence: 1
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
EISSN 2288-2413
EndPage 157
ExternalDocumentID oai_kci_go_kr_ARTI_10029887
oai:pubmedcentral.nih.gov:9353160
PMC9353160
10_14791_btrt_2022_0017
GrantInformation_xml – fundername: ;
  grantid: IBS-R006-A1
GroupedDBID 5-W
8JR
8XY
AAYXX
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
GX1
HYE
HZB
KQ8
M48
OK1
PGMZT
RPM
7X8
5PM
ADTOC
UNPAY
ACYCR
ID FETCH-LOGICAL-c3227-f0f276a1d18e305e00da02c933ccfa494367e1e47b31eb2168ddb3f17b6ff5f3
IEDL.DBID M48
ISSN 2288-2405
2288-2413
IngestDate Tue Nov 21 21:26:23 EST 2023
Sun Oct 26 04:04:48 EDT 2025
Thu Aug 21 18:15:43 EDT 2025
Thu Jul 10 21:35:04 EDT 2025
Tue Jul 01 03:55:19 EDT 2025
Thu Apr 24 23:12:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
other-oa
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3227-f0f276a1d18e305e00da02c933ccfa494367e1e47b31eb2168ddb3f17b6ff5f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
https://doi.org/10.14791/btrt.2022.0017
ORCID 0000-0002-0412-2270
0000-0002-4722-1893
0000-0002-4771-3396
0000-0002-3797-8024
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.14791/btrt.2022.0017
PMID 35929112
PQID 2699708403
PQPubID 23479
PageCount 7
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_10029887
unpaywall_primary_10_14791_btrt_2022_0017
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9353160
proquest_miscellaneous_2699708403
crossref_citationtrail_10_14791_btrt_2022_0017
crossref_primary_10_14791_btrt_2022_0017
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20220701
PublicationDateYYYYMMDD 2022-07-01
PublicationDate_xml – month: 7
  year: 2022
  text: 20220701
  day: 1
PublicationDecade 2020
PublicationTitle Brain tumor research and treatment
PublicationYear 2022
Publisher The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
대한뇌종양학회
Publisher_xml – name: The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
– name: 대한뇌종양학회
References Mathios (10.14791/btrt.2022.0017_ref35) 2016; 8
Alli (10.14791/btrt.2022.0017_ref16) 2018; 281
Jain (10.14791/btrt.2022.0017_ref18) 2018; 8
Meng (10.14791/btrt.2022.0017_ref50) 2020; 11
Shi (10.14791/btrt.2022.0017_ref52) 2016; 6
van Solinge (10.14791/btrt.2022.0017_ref25) 2022; 18
Cha (10.14791/btrt.2022.0017_ref53) 2022; 16
Lee (10.14791/btrt.2022.0017_ref58) 2019; 10
Westphal (10.14791/btrt.2022.0017_ref41) 2003; 5
Lau (10.14791/btrt.2022.0017_ref43) 2012; 4
Bastiancich (10.14791/btrt.2022.0017_ref51) 2017; 264
Kleinberg (10.14791/btrt.2022.0017_ref42) 2016; 10
Kim (10.14791/btrt.2022.0017_ref20) 2016; 7
Sunwoo (10.14791/btrt.2022.0017_ref33) 2021; 12
Ibrahim (10.14791/btrt.2022.0017_ref40) 2022; 14
Dirkse (10.14791/btrt.2022.0017_ref8) 2019; 10
Koo (10.14791/btrt.2022.0017_ref31) 2020; 5
Joo (10.14791/btrt.2022.0017_ref28) 2021; 7
Nam (10.14791/btrt.2022.0017_ref17) 2018; 11
Jain (10.14791/btrt.2022.0017_ref55) 2014; 13
Cha (10.14791/btrt.2022.0017_ref10) 2020; 328
Nance (10.14791/btrt.2022.0017_ref19) 2014; 8
Komotar (10.14791/btrt.2022.0017_ref5) 2008; 2
Ruan (10.14791/btrt.2022.0017_ref13) 2016; 10
Lesniak (10.14791/btrt.2022.0017_ref34) 2004; 3
Xue (10.14791/btrt.2022.0017_ref11) 2017; 12
Han (10.14791/btrt.2022.0017_ref23) 2019; 9
Jung (10.14791/btrt.2022.0017_ref7) 2021; 12
Wang (10.14791/btrt.2022.0017_ref37) 2021; 5
Pena (10.14791/btrt.2022.0017_ref38) 2021; 22
Bastiancich (10.14791/btrt.2022.0017_ref46) 2019; 559
Tran (10.14791/btrt.2022.0017_ref2) 2010; 17
Cha (10.14791/btrt.2022.0017_ref56) 2019; 8
Magill (10.14791/btrt.2022.0017_ref44) 2020; 12
Holland (10.14791/btrt.2022.0017_ref3) 2000; 97
Lee (10.14791/btrt.2022.0017_ref26) 2021; 72
Ganipineni (10.14791/btrt.2022.0017_ref6) 2018; 281
Wen (10.14791/btrt.2022.0017_ref15) 2020; 237
Wilhelm (10.14791/btrt.2022.0017_ref12) 2016; 1
Colen (10.14791/btrt.2022.0017_ref24) 2011; 3
Koo (10.14791/btrt.2022.0017_ref29) 2021; 3
Lee (10.14791/btrt.2022.0017_ref57) 2021; 33
Di Mascolo (10.14791/btrt.2022.0017_ref49) 2021; 16
Yoo (10.14791/btrt.2022.0017_ref32) 2021; 10
Shen (10.14791/btrt.2022.0017_ref14) 2018; 12
Abbott (10.14791/btrt.2022.0017_ref9) 2006; 7
Das (10.14791/btrt.2022.0017_ref1) 2018; 19
Zhang (10.14791/btrt.2022.0017_ref21) 2017; 263
Engelberth (10.14791/btrt.2022.0017_ref39) 2014; 19
Ramachandran (10.14791/btrt.2022.0017_ref48) 2017; 7
Szvalb (10.14791/btrt.2022.0017_ref45) 2014; 68
Cho (10.14791/btrt.2022.0017_ref30) 2022; 122
Zhang (10.14791/btrt.2022.0017_ref47) 2021; 16
Sunwoo (10.14791/btrt.2022.0017_ref27) 2020; 3
Cha (10.14791/btrt.2022.0017_ref54) 2020; 12
Das (10.14791/btrt.2022.0017_ref4) 2013; 369
Stephen (10.14791/btrt.2022.0017_ref22) 2014; 8
Allard (10.14791/btrt.2022.0017_ref36) 2009; 30
References_xml – volume: 8
  start-page: 1801660
  year: 2019
  ident: 10.14791/btrt.2022.0017_ref56
  publication-title: Adv Healthc Mater
  doi: 10.1002/adhm.201801660
– volume: 10
  start-page: 10086
  year: 2016
  ident: 10.14791/btrt.2022.0017_ref13
  publication-title: ACS Nano
  doi: 10.1021/acsnano.6b05070
– volume: 30
  start-page: 2302
  year: 2009
  ident: 10.14791/btrt.2022.0017_ref36
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2009.01.003
– volume: 122
  start-page: 5068
  year: 2022
  ident: 10.14791/btrt.2022.0017_ref30
  publication-title: Chem Rev
  doi: 10.1021/acs.chemrev.1c00531
– volume: 14
  start-page: 254
  year: 2022
  ident: 10.14791/btrt.2022.0017_ref40
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics14020254
– volume: 22
  start-page: 13160
  year: 2021
  ident: 10.14791/btrt.2022.0017_ref38
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms222313160
– volume: 7
  start-page: 43271
  year: 2017
  ident: 10.14791/btrt.2022.0017_ref48
  publication-title: Sci Rep
  doi: 10.1038/srep43271
– volume: 264
  start-page: 45
  year: 2017
  ident: 10.14791/btrt.2022.0017_ref51
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2017.08.019
– volume: 10
  start-page: 2397
  year: 2016
  ident: 10.14791/btrt.2022.0017_ref42
  publication-title: Patient Prefer Adherence
  doi: 10.2147/PPA.S93020
– volume: 10
  start-page: 5205
  year: 2019
  ident: 10.14791/btrt.2022.0017_ref58
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-13198-y
– volume: 17
  start-page: 417
  year: 2010
  ident: 10.14791/btrt.2022.0017_ref2
  publication-title: J Clin Neurosci
  doi: 10.1016/j.jocn.2009.09.004
– volume: 12
  start-page: 692
  year: 2017
  ident: 10.14791/btrt.2022.0017_ref11
  publication-title: Nat Nanotechnol
  doi: 10.1038/nnano.2017.54
– volume: 281
  start-page: 42
  year: 2018
  ident: 10.14791/btrt.2022.0017_ref6
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2018.05.008
– volume: 7
  start-page: 29400
  year: 2016
  ident: 10.14791/btrt.2022.0017_ref20
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.8837
– volume: 5
  start-page: 202000407
  year: 2020
  ident: 10.14791/btrt.2022.0017_ref31
  publication-title: Adv Mater Technol
– volume: 2
  start-page: 421
  year: 2008
  ident: 10.14791/btrt.2022.0017_ref5
  publication-title: Clin Med Oncol
– volume: 18
  start-page: 221
  year: 2022
  ident: 10.14791/btrt.2022.0017_ref25
  publication-title: Nat Rev Neurol
  doi: 10.1038/s41582-022-00621-0
– volume: 12
  start-page: 359
  year: 2021
  ident: 10.14791/btrt.2022.0017_ref33
  publication-title: Annu Rev Chem Biomol Eng
  doi: 10.1146/annurev-chembioeng-101420-024336
– volume: 13
  start-page: 308
  year: 2014
  ident: 10.14791/btrt.2022.0017_ref55
  publication-title: Nat Mater
  doi: 10.1038/nmat3878
– volume: 263
  start-page: 112
  year: 2017
  ident: 10.14791/btrt.2022.0017_ref21
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2017.03.007
– volume: 328
  start-page: 350
  year: 2020
  ident: 10.14791/btrt.2022.0017_ref10
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2020.09.002
– volume: 8
  start-page: 370ra180
  year: 2016
  ident: 10.14791/btrt.2022.0017_ref35
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.aag2942
– volume: 97
  start-page: 6242
  year: 2000
  ident: 10.14791/btrt.2022.0017_ref3
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.97.12.6242
– volume: 8
  start-page: 10383
  year: 2014
  ident: 10.14791/btrt.2022.0017_ref22
  publication-title: ACS Nano
  doi: 10.1021/nn503735w
– volume: 3
  start-page: 266
  year: 2011
  ident: 10.14791/btrt.2022.0017_ref24
  publication-title: World J Radiol
  doi: 10.4329/wjr.v3.i11.266
– volume: 12
  start-page: 10456
  year: 2020
  ident: 10.14791/btrt.2022.0017_ref54
  publication-title: Nanoscale
  doi: 10.1039/D0NR01456G
– volume: 10
  start-page: 1787
  year: 2019
  ident: 10.14791/btrt.2022.0017_ref8
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-09853-z
– volume: 68
  start-page: 216
  year: 2014
  ident: 10.14791/btrt.2022.0017_ref45
  publication-title: J Infect
  doi: 10.1016/j.jinf.2013.12.002
– volume: 1
  start-page: 16014
  year: 2016
  ident: 10.14791/btrt.2022.0017_ref12
  publication-title: Nat Rev Mater
  doi: 10.1038/natrevmats.2016.14
– volume: 33
  start-page: 2100425
  year: 2021
  ident: 10.14791/btrt.2022.0017_ref57
  publication-title: Adv Mater
  doi: 10.1002/adma.202100425
– volume: 12
  start-page: 1014
  year: 2021
  ident: 10.14791/btrt.2022.0017_ref7
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-21117-3
– volume: 16
  start-page: 538
  year: 2021
  ident: 10.14791/btrt.2022.0017_ref47
  publication-title: Nat Nanotechnol
  doi: 10.1038/s41565-020-00843-7
– volume: 72
  start-page: 13
  year: 2021
  ident: 10.14791/btrt.2022.0017_ref26
  publication-title: Curr Opin Biotechnol
  doi: 10.1016/j.copbio.2021.07.027
– volume: 237
  start-page: 119793
  year: 2020
  ident: 10.14791/btrt.2022.0017_ref15
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2020.119793
– volume: 19
  start-page: e514
  year: 2018
  ident: 10.14791/btrt.2022.0017_ref1
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(18)30665-X
– volume: 7
  start-page: 41
  year: 2006
  ident: 10.14791/btrt.2022.0017_ref9
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn1824
– volume: 11
  start-page: 594
  year: 2020
  ident: 10.14791/btrt.2022.0017_ref50
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-14036-x
– volume: 12
  start-page: 11355
  year: 2018
  ident: 10.14791/btrt.2022.0017_ref14
  publication-title: ACS Nano
  doi: 10.1021/acsnano.8b06201
– volume: 369
  start-page: 1561
  year: 2013
  ident: 10.14791/btrt.2022.0017_ref4
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcibr1309402
– volume: 3
  start-page: 499
  year: 2004
  ident: 10.14791/btrt.2022.0017_ref34
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd1414
– volume: 10
  start-page: 2100614
  year: 2021
  ident: 10.14791/btrt.2022.0017_ref32
  publication-title: Adv Healthc Mater
  doi: 10.1002/adhm.202100614
– volume: 3
  start-page: 1923
  year: 2020
  ident: 10.14791/btrt.2022.0017_ref27
  publication-title: Matter
  doi: 10.1016/j.matt.2020.10.020
– volume: 11
  start-page: 779
  year: 2018
  ident: 10.14791/btrt.2022.0017_ref17
  publication-title: Materials (Basel)
  doi: 10.3390/ma11050779
– volume: 8
  start-page: 419
  year: 2018
  ident: 10.14791/btrt.2022.0017_ref18
  publication-title: Front Oncol
  doi: 10.3389/fonc.2018.00419
– volume: 16
  start-page: 820
  year: 2021
  ident: 10.14791/btrt.2022.0017_ref49
  publication-title: Nat Nanotechnol
  doi: 10.1038/s41565-021-00879-3
– volume: 559
  start-page: 220
  year: 2019
  ident: 10.14791/btrt.2022.0017_ref46
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2019.01.042
– volume: 5
  start-page: 79
  year: 2003
  ident: 10.14791/btrt.2022.0017_ref41
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/5.2.79
– volume: 281
  start-page: 29
  year: 2018
  ident: 10.14791/btrt.2022.0017_ref16
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2018.05.005
– volume: 6
  start-page: 19077
  year: 2016
  ident: 10.14791/btrt.2022.0017_ref52
  publication-title: Sci Rep
  doi: 10.1038/srep19077
– volume: 7
  start-page: eabd4639
  year: 2021
  ident: 10.14791/btrt.2022.0017_ref28
  publication-title: Sci Adv
  doi: 10.1126/sciadv.abd4639
– volume: 5
  start-page: 1048
  year: 2021
  ident: 10.14791/btrt.2022.0017_ref37
  publication-title: Nat Biomed Eng
  doi: 10.1038/s41551-021-00728-7
– volume: 3
  start-page: 1528
  year: 2021
  ident: 10.14791/btrt.2022.0017_ref29
  publication-title: ACS Mater Lett
  doi: 10.1021/acsmaterialslett.1c00438
– volume: 9
  start-page: 17936
  year: 2019
  ident: 10.14791/btrt.2022.0017_ref23
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-54283-y
– volume: 8
  start-page: 10655
  year: 2014
  ident: 10.14791/btrt.2022.0017_ref19
  publication-title: ACS Nano
  doi: 10.1021/nn504210g
– volume: 4
  start-page: e66
  year: 2012
  ident: 10.14791/btrt.2022.0017_ref43
  publication-title: Cureus
– volume: 16
  start-page: 554
  year: 2022
  ident: 10.14791/btrt.2022.0017_ref53
  publication-title: ACS Nano
  doi: 10.1021/acsnano.1c07649
– volume: 19
  start-page: 281
  year: 2014
  ident: 10.14791/btrt.2022.0017_ref39
  publication-title: Crit Rev Oncog
  doi: 10.1615/CritRevOncog.2014011455
– volume: 12
  start-page: e7731
  year: 2020
  ident: 10.14791/btrt.2022.0017_ref44
  publication-title: Cureus
SSID ssj0001255777
Score 2.3099906
SecondaryResourceType review_article
Snippet Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high...
Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the lim- ited efficacy of standard treatment is the high...
SourceID nrf
unpaywall
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 151
SubjectTerms Review
신경외과학
SummonAdditionalLinks – databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwFHwq2wNc-BAgwpeC4ACHZOM4sdfHilIKggqhrVROlu3Y7WqzySpNhMqvxy-bLGwlhHqKpTiJk7HjefJ4HsAbazwr4E5F6P8UZUr7MdcvOCpP7tnMckVxc_LXE3Z8mn0-y8_2gIx7YXrRvtGLuCpXcbW46LWV65WZjjqxqaC-2zAfpe-z3NPvCeyfnnw7-IFJ5FJEPetli0OZ0MHOJ-OCTHXboHwyRY_OPkPZn5noVtW4HZJ5XSJ5u6vW6uqnKsu_5p-je_B9bPlGdrKMu1bH5tc1U8cbvdp9uDuw0fBgc-oB7NnqIYgvOL-Fh013Hh7aEoUbV-HoYmsvQ09zw4_lotaeeLf1SoXzUaz-COZHH-bvj6Mhw0Jk_EDmkUtcypkiBZlZP_BtkhQqSY2g1BinMpFRxi2xGdeU-BCcsFlRaOoI18y53NHHMKnqyj6BUKjcJIqZIs_TjHOn6cwQbjIjdC7SRAcQjx9bmsF9HJNglBKjEERHIjoS0UGdHQ_g7faC9cZ4499VX3v05NIsJJpl4_G8lstG-pDgE5oyp8L_SgN4NaIr_RDCdRFV2bq7lCkTgic-0qUB8B3Yt0_G--6e8QD2ZtwDZgG823aQ_7X36Q3qPoM7WN4IhJ_DpG06-8LToFa_HDr-b0TKBqA
  priority: 102
  providerName: Unpaywall
Title Local Drug Delivery Strategies for Glioblastoma Treatment
URI https://www.proquest.com/docview/2699708403
https://pubmed.ncbi.nlm.nih.gov/PMC9353160
https://www.ncbi.nlm.nih.gov/pmc/articles/9353160
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002863747
UnpaywallVersion submittedVersion
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Brain Tumor Research and Treatment, 2022, 10(3), , pp.151-157
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2288-2413
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001255777
  issn: 2288-2413
  databaseCode: KQ8
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2288-2413
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001255777
  issn: 2288-2413
  databaseCode: DIK
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 2288-2413
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001255777
  issn: 2288-2413
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVERR
  databaseName: [Open Access] KoreaMed
  customDbUrl:
  eissn: 2288-2413
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001255777
  issn: 2288-2413
  databaseCode: 5-W
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2288-2413
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001255777
  issn: 2288-2413
  databaseCode: RPM
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2288-2413
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0001255777
  issn: 2288-2413
  databaseCode: M48
  dateStart: 20130401
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Bb9MwFH5imwS7IBAgAqMKggMcMuI4sesDQhNjDMQmDq00Tpbt2KNaSLa0FfTf816aFoqGkDjlkMSOPvv5fc9--R7Ac--QFchgEtJ_SnJj0ea6A0eD5F4MvTScfk4-ORXH4_zjWXH2qxxQD-D02tCO6kmN22r_x9XiDRr8azL4XCr2ys5aSovMSHuTyS3YQTelqI7DSc_1lxsuRSG7SoxZRrMDmUov9XNNG7twkxfIHBjLNhzWVt2GDS76ZyblrXl9aRbfTVX95qaO7sDtnl_GB8sJcRdu-PoeqE_kseLDdn4eH_qKUjEW8UqX1k9jJK7x-2rSWKTSs-abiUer9PP7MDp6N3p7nPQ1ExKHpimTkIZMCsNKNvRoyj5NS5NmTnHuXDC5yrmQnvlcWs4wqGZiWJaWByatCKEI_AFs103tH0KsTOFSI1xZFFkuZbB86Jh0uVMWkUltBPsrXLTr9cSprEWlKa4gTDVhqglTypyTEbxYv3C5lNL4-6PPEGh94Saa5K_pet7oi1Yjyf9AMsuZwsUxgqergdBoFHTSYWrfzKc6E0rJFGNXHoHcGKF1z9Tu5p168rWT11Yc1yWRRvByPZb_-t5H_93LY9ilVpYJwHuwPWvn_gnSnJkddNN30O0_DWBnfPr54MtP6TL9gw
linkProvider Scholars Portal
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwFHwq2wNc-BAgwpeC4ACHZOM4sdfHilIKggqhrVROlu3Y7WqzySpNhMqvxy-bLGwlhHqKpTiJk7HjefJ4HsAbazwr4E5F6P8UZUr7MdcvOCpP7tnMckVxc_LXE3Z8mn0-y8_2gIx7YXrRvtGLuCpXcbW46LWV65WZjjqxqaC-2zAfpe-z3NPvCeyfnnw7-IFJ5FJEPetli0OZ0MHOJ-OCTHXboHwyRY_OPkPZn5noVtW4HZJ5XSJ5u6vW6uqnKsu_5p-je_B9bPlGdrKMu1bH5tc1U8cbvdp9uDuw0fBgc-oB7NnqIYgvOL-Fh013Hh7aEoUbV-HoYmsvQ09zw4_lotaeeLf1SoXzUaz-COZHH-bvj6Mhw0Jk_EDmkUtcypkiBZlZP_BtkhQqSY2g1BinMpFRxi2xGdeU-BCcsFlRaOoI18y53NHHMKnqyj6BUKjcJIqZIs_TjHOn6cwQbjIjdC7SRAcQjx9bmsF9HJNglBKjEERHIjoS0UGdHQ_g7faC9cZ4499VX3v05NIsJJpl4_G8lstG-pDgE5oyp8L_SgN4NaIr_RDCdRFV2bq7lCkTgic-0qUB8B3Yt0_G--6e8QD2ZtwDZgG823aQ_7X36Q3qPoM7WN4IhJ_DpG06-8LToFa_HDr-b0TKBqA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Local+Drug+Delivery+Strategies+for+Glioblastoma+Treatment&rft.jtitle=Brain+tumor+research+and+treatment&rft.au=Cha%2C+Gi+Doo&rft.au=Jung%2C+Sonwoo&rft.au=Choi%2C+Seung+Hong&rft.au=Kim%2C+Dae-Hyeong&rft.date=2022-07-01&rft.pub=The+Korean+Brain+Tumor+Society%3B+The+Korean+Society+for+Neuro-Oncology%3B+The+Korean+Society+for+Pediatric+Neuro-Oncology&rft.issn=2288-2405&rft.eissn=2288-2413&rft.volume=10&rft.issue=3&rft.spage=151&rft.epage=157&rft_id=info:doi/10.14791%2Fbtrt.2022.0017&rft_id=info%3Apmid%2F35929112&rft.externalDocID=PMC9353160
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2288-2405&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2288-2405&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2288-2405&client=summon